Compile Data Set for Download or QSAR
maximum 50k data
Found 20 Enz. Inhib. hit(s) with all data for entry = 7178
TargetPhospholipase D1(Homo sapiens (Human))
Vanderbilt University

US Patent
LigandPNGBDBM179748(US9127005, P22)
Affinity DataIC50:  73nMAssay Description:In one aspect, the compound inhibits PLD activity; that is, a compound can inhibit PLD1 activity and/or PLD2 activity. In a further aspect, the compo...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhospholipase D1(Homo sapiens (Human))
Vanderbilt University

US Patent
LigandPNGBDBM179736(US9127005, P0L)
Affinity DataIC50:  100nMAssay Description:In one aspect, the compound inhibits PLD activity; that is, a compound can inhibit PLD1 activity and/or PLD2 activity. In a further aspect, the compo...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhospholipase D1(Homo sapiens (Human))
Vanderbilt University

US Patent
LigandPNGBDBM179741(US9127005, CTH Racemic mixture | US9127005, P1P)
Affinity DataIC50:  450nMAssay Description:In one aspect, the compound inhibits PLD activity; that is, a compound can inhibit PLD1 activity and/or PLD2 activity. In a further aspect, the compo...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhospholipase D1(Homo sapiens (Human))
Vanderbilt University

US Patent
LigandPNGBDBM179738(US9127005, NFW)
Affinity DataIC50:  480nMAssay Description:In one aspect, the compound inhibits PLD activity; that is, a compound can inhibit PLD1 activity and/or PLD2 activity. In a further aspect, the compo...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhospholipase D1(Homo sapiens (Human))
Vanderbilt University

US Patent
LigandPNGBDBM179736(US9127005, P0L)
Affinity DataIC50:  725nMAssay Description:In one aspect, the compound inhibits PLD activity; that is, a compound can inhibit PLD1 activity and/or PLD2 activity. In a further aspect, the compo...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhospholipase D1(Homo sapiens (Human))
Vanderbilt University

US Patent
LigandPNGBDBM179733(US9127005, NGH)
Affinity DataIC50:  1.20E+3nMAssay Description:In one aspect, the compound inhibits PLD activity; that is, a compound can inhibit PLD1 activity and/or PLD2 activity. In a further aspect, the compo...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhospholipase D1(Homo sapiens (Human))
Vanderbilt University

US Patent
LigandPNGBDBM179741(US9127005, CTH Racemic mixture | US9127005, P1P)
Affinity DataIC50:  1.97E+3nMAssay Description:In one aspect, the compound inhibits PLD activity; that is, a compound can inhibit PLD1 activity and/or PLD2 activity. In a further aspect, the compo...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhospholipase D1(Homo sapiens (Human))
Vanderbilt University

US Patent
LigandPNGBDBM179733(US9127005, NGH)
Affinity DataIC50:  2.24E+3nMAssay Description:In one aspect, the compound inhibits PLD activity; that is, a compound can inhibit PLD1 activity and/or PLD2 activity. In a further aspect, the compo...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhospholipase D1(Homo sapiens (Human))
Vanderbilt University

US Patent
LigandPNGBDBM179748(US9127005, P22)
Affinity DataIC50:  3.90E+3nMAssay Description:In one aspect, the compound inhibits PLD activity; that is, a compound can inhibit PLD1 activity and/or PLD2 activity. In a further aspect, the compo...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhospholipase D1(Homo sapiens (Human))
Vanderbilt University

US Patent
LigandPNGBDBM179747(US9127005, NFT)
Affinity DataIC50:  5.05E+3nMAssay Description:In one aspect, the compound inhibits PLD activity; that is, a compound can inhibit PLD1 activity and/or PLD2 activity. In a further aspect, the compo...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhospholipase D1(Homo sapiens (Human))
Vanderbilt University

US Patent
LigandPNGBDBM179741(US9127005, CTH Racemic mixture | US9127005, P1P)
Affinity DataIC50:  5.05E+3nMAssay Description:In one aspect, the compound inhibits PLD activity; that is, a compound can inhibit PLD1 activity and/or PLD2 activity. In a further aspect, the compo...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhospholipase D1(Homo sapiens (Human))
Vanderbilt University

US Patent
LigandPNGBDBM179746(US9127005, P2E)
Affinity DataIC50:  5.13E+3nMAssay Description:In one aspect, the compound inhibits PLD activity; that is, a compound can inhibit PLD1 activity and/or PLD2 activity. In a further aspect, the compo...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhospholipase D1(Homo sapiens (Human))
Vanderbilt University

US Patent
LigandPNGBDBM179743(US9127005, P2B)
Affinity DataIC50:  5.15E+3nMAssay Description:In one aspect, the compound inhibits PLD activity; that is, a compound can inhibit PLD1 activity and/or PLD2 activity. In a further aspect, the compo...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhospholipase D1(Homo sapiens (Human))
Vanderbilt University

US Patent
LigandPNGBDBM179746(US9127005, P2E)
Affinity DataIC50:  6.75E+3nMAssay Description:In one aspect, the compound inhibits PLD activity; that is, a compound can inhibit PLD1 activity and/or PLD2 activity. In a further aspect, the compo...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhospholipase D1(Homo sapiens (Human))
Vanderbilt University

US Patent
LigandPNGBDBM179743(US9127005, P2B)
Affinity DataIC50:  9.44E+3nMAssay Description:In one aspect, the compound inhibits PLD activity; that is, a compound can inhibit PLD1 activity and/or PLD2 activity. In a further aspect, the compo...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhospholipase D1(Homo sapiens (Human))
Vanderbilt University

US Patent
LigandPNGBDBM179738(US9127005, NFW)
Affinity DataIC50:  1.10E+4nMAssay Description:In one aspect, the compound inhibits PLD activity; that is, a compound can inhibit PLD1 activity and/or PLD2 activity. In a further aspect, the compo...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhospholipase D1(Homo sapiens (Human))
Vanderbilt University

US Patent
LigandPNGBDBM179751(US9127005, P2C)
Affinity DataIC50: >2.00E+4nMAssay Description:In one aspect, the compound inhibits PLD activity; that is, a compound can inhibit PLD1 activity and/or PLD2 activity. In a further aspect, the compo...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhospholipase D1(Homo sapiens (Human))
Vanderbilt University

US Patent
LigandPNGBDBM179747(US9127005, NFT)
Affinity DataIC50: >2.00E+4nMAssay Description:In one aspect, the compound inhibits PLD activity; that is, a compound can inhibit PLD1 activity and/or PLD2 activity. In a further aspect, the compo...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhospholipase D1(Homo sapiens (Human))
Vanderbilt University

US Patent
LigandPNGBDBM179751(US9127005, P2C)
Affinity DataIC50: >2.00E+4nMAssay Description:In one aspect, the compound inhibits PLD activity; that is, a compound can inhibit PLD1 activity and/or PLD2 activity. In a further aspect, the compo...More data for this Ligand-Target Pair
In DepthDetails US Patent
TargetPhospholipase D1(Homo sapiens (Human))
Vanderbilt University

US Patent
LigandPNGBDBM179741(US9127005, CTH Racemic mixture | US9127005, P1P)
Affinity DataIC50: >2.00E+4nMAssay Description:In one aspect, the compound inhibits PLD activity; that is, a compound can inhibit PLD1 activity and/or PLD2 activity. In a further aspect, the compo...More data for this Ligand-Target Pair
In DepthDetails US Patent